BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34945043)

  • 21. Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Int Urol Nephrol; 2021 Aug; 53(8):1631-1638. PubMed ID: 33428165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Lee LE; Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2021; 39 Suppl 129(2):88-93. PubMed ID: 33200738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases.
    Pyo JY; Ahn SS; Lee LE; Choi GM; Song JJ; Park YB; Lee SW
    Clinics (Sao Paulo); 2021; 76():e2501. PubMed ID: 33852653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary Matrix Metalloproteinase 7 Activated by Oxidative Stress Predicts Kidney Prognosis in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu L; Wang G; Yang B; Liu X; Xie C; Feng X; Jin L; Zhou Z; Yang M; Zhou Z; Su C; Li Y; Song Y; Cao W
    Antioxid Redox Signal; 2022 Aug; 37(4-6):246-256. PubMed ID: 35152729
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
    Ahn SS; Kim JO; Yoon T; Song JJ; Park YB; Lee SW; Park SG
    Biomed Res Int; 2019; 2019():7508240. PubMed ID: 31236412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Do H; Song JJ; Park YB; Lee SW
    J Clin Lab Anal; 2021 Aug; 35(8):e23885. PubMed ID: 34181278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Cho M; Rah W; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541107
    [No Abstract]   [Full Text] [Related]  

  • 28. Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    J Rheum Dis; 2022 Jul; 29(3):154-161. PubMed ID: 37475972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum soluble programmed cell death protein 1 could predict the current activity and severity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.
    Yoon T; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2019; 37 Suppl 117(2):116-121. PubMed ID: 30873951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Lee TG; Park PG; Park YB; Huh JH; Lee SW
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Kidney Injury: Short-Term Recovery Predicts Long-Term Outcome.
    Huang X; Chen L; Lan L; Ren P; Ni A; Ma Y; Wang Y; Zhu Y; Xu Y; Chen J; Han F
    Front Immunol; 2021; 12():641655. PubMed ID: 34305886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the fibrosis index for predicting end-stage renal disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Pyo JY; Ahn SS; Lee LE; Choe HN; Song JJ; Park YB; Lee SW
    Int J Clin Pract; 2021 Apr; 75(4):e13929. PubMed ID: 33301633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study.
    Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    BMC Nephrol; 2018 Jul; 19(1):187. PubMed ID: 30064369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis.
    Boud'hors C; Riou J; Fage N; Samoreau C; Desouche A; Gatault P; Bridoux F; Martin C; Wacrenier S; Vinatier E; Djema A; Henry N; Croué A; Piccoli GB; Copin MC; Augusto JF; Brilland B;
    Clin Kidney J; 2023 Dec; 16(12):2530-2541. PubMed ID: 38046032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-Reactive Protein to Serum Albumin Ratio Is an Independent Predictor of All-Cause Mortality in Patients with ANCA-Associated Vasculitis.
    Moon JS; Ahn SS; Park YB; Lee SK; Lee SW
    Yonsei Med J; 2018 Sep; 59(7):865-871. PubMed ID: 30091320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet to lymphocyte ratio is associated with the current activity of ANCA-associated vasculitis at diagnosis: a retrospective monocentric study.
    Park HJ; Jung SM; Song JJ; Park YB; Lee SW
    Rheumatol Int; 2018 Oct; 38(10):1865-1871. PubMed ID: 30088046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort.
    McGovern DP; Lees JS; Traynor JP; Mackinnon B; Bell S; Hunter RW; Dhaun N; Metcalfe W; Kidder D; Lim M; Joss N; Kelly M; Taylor A; Cousland Z; Dey V; Buck K; Brix S; Geddes CC; McQuarrie EP; Stevens KI
    Kidney Int Rep; 2023 Aug; 8(8):1648-1656. PubMed ID: 37547534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations.
    Casal Moura M; Crowson CS; Specks U; Warrington KJ; Zand L; Sethi S; Fervenza FC
    Clin Kidney J; 2023 Mar; 16(3):432-436. PubMed ID: 36865008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANCA-associated vasculitis in Ireland: a multi-centre national cohort study.
    Scott J; Nic An Ríogh E; Al Nokhatha S; Cowhig C; Verrelli A; Fitzgerald T; White A; Walsh C; Aslett L; DeFreitas D; Clarkson MR; Holian J; Griffin MD; Conlon N; O'Meara Y; Casserly L; Molloy E; Power J; Moran SM; Little MA
    HRB Open Res; 2022; 5():80. PubMed ID: 37251362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.